Host defenses in experimental scrub typhus: effect of chloramphenicol.
The effect of chloramphenicol treatment on the development of immunity to scrub typhus in mice was studied. Chemotherapy was administered either shortly before infection and for 14 days thereafter (group I), or from 7 to 21 days postinfection (group II). Although the full course of either regimen resulted in complete protection of the mice against subsequent challenge with the homologous strain of Rickettsia tsutsugamushi, initiation of chemotherapy at 7 days postinfection resulted in more rapid development of immunity against both the original infection and subsequent challenge. In both treatment groups, a 1- to 2- day hiatus was observed between immunity to challenge in the treated animal and the ability to transfer this immunity to syngeneic recipients with lymphocyte-enriched spleen cells. Similarly, complement-fixing antibodies were not detectable until shortly after the animals were able to resist challenge. These data supported the conclusion that the rickettsiostatic effect of chloramphenicol allows the infected animal time to mount an effective immune response and, further, that initiation of chemotherapy early in the infection may delay development of this response.
D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D002701:Chloramphenicol / Q000627:therapeutic use*; D005260:Female; D007109:Immunity; D007116:Immunization, Passive; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D012285:Orientia tsutsugamushi / Q000254:growth & development / Q000276:immunology / Q000302:isolation & purification; D012612:Scrub Typhus / Q000188:drug therapy / Q000276:immunology*; D013154:Spleen / Q000382:microbiology
D000907:Antibodies, Bacterial; D002701:Chloramphenicol